Cancer immune cycle: a video introduction to the interaction between cancer and the immune system

Por Preusser, Matthias, Berghoff, Anna S, Thallinger, Christiane, Zielinski, Christoph C
Publicado no ESMO Open (2016)

Reply to Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Por Bracale, Umberto, Sodo, Maurizio, Merola, Giovanni, Di Salvo, Enrico
Publicado no ESMO Open (2016)

Response: Effects of physical activity on depressive symptoms during breast cancer survivorship: a meta-analysis of randomised control trials

Por Patsou, Efrossini D, Karamouzis, Michalis V
Publicado no ESMO Open (2018)

Role of chemotherapy in resectable liver metastases from colorectal cancer: food for thought from pooled evidence

Por Mauri, Davide, Filis, Panagiotis, Tsali, Lampriani, Zarkavelis, George, Pentheroudakis, George
Publicado no ESMO Open (2018)

Is smoking history the truly best biomarker for immune checkpoint inhibitor treatment in advanced non-small cell lung cancer?

Por Pirker, Robert
Publicado no ESMO Open (2018)

Immune checkpoint inhibitors for every patient with non-small cell lung cancer? Update on immunotherapy in patients with lung cancer

Por Vansteenkiste, Johan F
Publicado no ESMO Open (2018)

Report from the ESMO 2018 presidential symposium—Radiotherapy to the primary tumour for men with newly diagnosed metastatic prostate cancer: survival results from STAMPEDE

Por Parker, Chris
Publicado no ESMO Open (2018)

Specific CDK4/6 inhibition in breast cancer: a systematic review of current clinical evidence

Por Polk, Anne, Kolmos, Ida Lykke, Kümler, Iben, Nielsen, Dorte Lisbeth
Publicado no ESMO Open (2017)

Prevalence of hypothyroidism among patients with breast cancer treated with radiation to the supraclavicular field: a single-centre survey

Por Kikawa, Yuichiro, Kosaka, Yasuhiro, Hashimoto, Kazuki, Hohokabe, Eri, Takebe, Sayaka, Narukami, Ryo, Hattori, Takayuki, Ueki, Kazuhiro, Ogura, Kengo, Imagumbai, Toshiyuki, Kato, Hironori, Kokubo, Masaki
Publicado no ESMO Open (2017)

Impact of intervention aimed at improving the integration of oncology units and local palliative care services: results of the multicentre prospective sequential MIRTO study

Por Martoni, Andrea A, Melotti, Barbara, Degli Esposti, Claudia, Mutri, Vita, Lelli, Giorgio, Ansaloni, Silvia, Piva, Erico, Strocchi, Elena, Pannuti, Franco
Publicado no ESMO Open (2017)

European Medicines Agency approval summary: Zaltrap for the treatment of patients with oxaliplatin-resistant metastatic colorectal cancer

Por Stanel, Stefan Cristian, Sjöberg, Jan, Salmonson, Tomas, Foggi, Paolo, Caleno, Mariapaola, Melchiorri, Daniela, Gravanis, Iordanis, Tzogani, Kyriaki, Pignatti, Francesco
Publicado no ESMO Open (2017)

Lactobacillus brevis CD2 lozenges prevent oral mucositis in patients undergoing high dose chemotherapy followed by haematopoietic stem cell transplantation

Por Sharma, Atul, Tilak, TVSVGK, Bakhshi, Sameer, Raina, Vinod, Kumar, Lalit, Chaudhary, Surendra Pal, Sahoo, Ranjit Kumar, Gupta, Ritu, Thulkar, Sanjay
Publicado no ESMO Open (2017)

Erlotinib intercalating pemetrexed/cisplatin versus erlotinib alone in Chinese patients with brain metastases from lung adenocarcinoma: a prospective, non-randomised, concurrent co...

Por Yang, Haihong, Deng, Qiuhua, Qiu, Yuan, Huang, Jun, Guan, Yubao, Wang, Fengnan, Xu, Xin, Yang, Xinyun
Publicado no ESMO Open (2017)

Single institution long-term efficacy and safety analysis of abiraterone acetate (AA) in the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC) in a...

Por Fröbe, Ana, Murgić, Jure, Rauh, Stefan
Publicado no ESMO Open (2016)

Quality to rely on: meeting report of the 5th Meeting of External Quality Assessment, Naples 2016

Por van Krieken, Han, Deans, Sandi, Hall, Jacqueline A, Normanno, Nicola, Ciardiello, Fortunato, Douillard, Jean-Yves
Publicado no ESMO Open (2016)

Nutrition in patients with cancer: a new area for medical oncologists? A practising oncologist’s interdisciplinary position paper

Por Rauh, Stefan, Antonuzzo, Andrea, Bossi, Paolo, Eckert, Robert, Fallon, Marie, Fröbe, Anna, Gonella, Silvia, Giusti, Raffaele, Lakatos, Gabor, Santini, Daniele, Villarini, Anna
Publicado no ESMO Open (2018)

The ESMO/ASCO Global Curriculum and the evolution of medical oncology training in Europe

Por Pavlidis, Nicholas, Alba, Emilio, Berardi, Rossana, Bergh, Jonas, El Saghir, Nagi, Jassem, Jacek, Kosty, Michael, Lopez, Roberto Ivan, Lotz, Jean-Pierre, Österlund, Pia, Purkalne, Gunta, Dittrich, Christian
Publicado no ESMO Open (2016)

Clonal evolution and KRAS-MET coamplification during secondary resistance to EGFR-targeted therapy in metastatic colorectal cancer

Por Sartore-Bianchi, Andrea, Valtorta, Emanuele, Amatu, Alessio, Veronese, Silvio, Lauricella, Calogero, Bonazzina, Erica, Siravegna, Giulia, Truini, Mauro, Bardelli, Alberto, Siena, Salvatore
Publicado no ESMO Open (2016)

Challenge of implementing clinical practice guidelines. Getting ESMO’s guidelines even closer to the bedside: introducing the ESMO Practising Oncologists’ checklists and knowledge...

Por Rauh, Stefan, Arnold, Dirk, Braga, Sofia, Curca, Razvan, Eckert, Robert, Fröbe, Ana, Karamouzis, Michalis, Lakatos, Gabor, Molitor, Jean-Luc
Publicado no ESMO Open (2018)

Time since start of first-line therapy as a predictive clinical marker for nintedanib in patients with previously treated non-small cell lung cancer

Por Gaschler-Markefski, Birgit, Sikken, Patricia, Heymach, John V, Gottfried, Maya, Mellemgaard, Anders, Novello, Silvia, Gann, Claudia-Nanette, Barrueco, José, Reck, Martin, Hanna, Nasser H, Kaiser, Rolf
Publicado no ESMO Open (2017)